Using Nanoliposomes to Make Cancer Therapies Safer and More Effective
RARECast - Un podcast de RARECast - Les jeudis
Catégories:
Marc Hedrick, CEO of Plus Therapeutics, discusses the company’s nanoliposome technology, how it works, and why the company is focusing on rare cancers.
